Skip to content

Clinical trials

Recruiting Anemia, Refractory, with Excess of Blasts trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory, with Excess of Blasts Status: Recruiting Country / region: China Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20241
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The First Affiliated Hospital of Soochow University2
Chaser Therapeutics, Inc.1
Cullgen (Shanghai),Inc1
First Affiliated Hospital of Zhejiang University1
Fujian Medical University Union Hospital1
Institute of Hematology & Blood Diseases Hospital, China1
Ruijin Hospital1
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory, with Excess of Blasts9
Leukemia, Myeloid, Acute8
Anemia, Aplastic1
Leukemia1
Leukemia, Myelomonocytic, Chronic1
Myelodysplastic Syndromes1
Recurrence1
Sarcoma, Myeloid1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.